English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Pharma & Biotech BioTech (Sci&Research)
Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa
Feb 12, 2021 13:00 HKT
Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial
Feb 11, 2021 21:00 HKT
Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China
Feb 11, 2021 11:00 HKT
Apollomics, Inc. and Edison Oncology Announce Licensing Agreement for Novel Protein Tyrosine Kinase Inhibitor Targeting Solid Tumors
Feb 10, 2021 10:10 HKT
Two Immigrants, One Unique Plan For A Biopharma
Feb 03, 2021 06:00 HKT
Lasting Antiviral Effect against Covid-19 virus (SARS-CoV-2) by TAKEX CLEAN EXTRA
Feb 02, 2021 11:00 HKT
Shanghai Longyao Chief Scientist Professor Xuanming Yang published a research article on optimizing CAR-T cells function with independently expressed full-length OX40
Jan 29, 2021 08:00 HKT
China Biotech Services LY007 Cell Injection Obtained Clinical Trial Approval Letter
Jan 28, 2021 09:50 HKT
New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific
Jan 28, 2021 07:00 HKT
New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific
Jan 28, 2021 01:30 HKT
Heathrow Covid Chaos British Tech Co Has Solution
Jan 22, 2021 16:00 HKT
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SN1011 in China
Jan 18, 2021 08:30 HKT
APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia
Jan 07, 2021 20:10 HKT
AIM ImmunoTech Announces that the ME/CFS Clinical Trial of its Drug Ampligen is Open for Enrollment to COVID-19 'Long Haulers'
Dec 24, 2020 21:00 HKT
China Medical System (00867.HK) MSCI-ESG Rating Upgraded to AA, Reaching Global Level
Dec 21, 2020 19:00 HKT
Hua Medicine Completes Registration Phase III Trials; Announces 52-Week Result for DAWN (HMM0302), Dorzagliatin's Phase III Combination with Metformin Trial
Dec 18, 2020 09:15 HKT
Captiva Verde Announces Mushroom Update to Agreement with Mexican Health Care Workers Union for up to USD $142 Million per Year of Annual Product Sales
Dec 15, 2020 10:00 HKT
Azooka Labs unveils Safe MTM to Store COVID-19 Samples at Room Temperature for up to a week
Dec 15, 2020 09:00 HKT
British Tech Company Launches Worlds First Secure Technology 'Fit To Fly' Health Passport for Air Travel 'VPassport'
Dec 14, 2020 15:00 HKT
Sino Biopharm Invests in Sinovac LS, A Leading COVID-19 Vaccine Company in China
Dec 07, 2020 08:55 HKT
<< Previous  Next >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: